Onco-nephrology is an emerging medical subspecialty concerned with the diagnosis and treatment of renal disease in cancer patients. Although kidney disease is very common in cancer patients, most nephrology trainees have little exposure to renal syndromes that are unique to patients with cancer, being caused either by the cancer itself or by its treatment.
Training in onco-nephrology provides experience in the management of:
- Nephrotoxicity from traditional chemotherapy as well as targeted therapy
- Renal disease after stem cell transplant
- Myeloma-related kidney disease
- Paraneoplastic renal disease
- Electrolyte disorders secondary to cancer or cancer therapy
Additional experience would be gained in critical care nephrology and renal replacement therapy. Furthermore, the fellow will gain valuable experience in the psychosocial aspects of renal replacement therapy during near-end of life care.
Cases that are rare in standard nephrology fellowship training programs are commonly seen by the Section of Nephrology at MD Anderson. After the completion of one year of training, the fellow will be expected to be knowledgeable about appropriate diagnostic and therapeutic approaches to cancer patients who present with renal complications.
The fellowship will be composed of nine months of clinical duties and three months devoted to research. Clinical duties will include providing care on the inpatient consult service as well as two half-day outpatient clinics. Research may be bench driven or clinical as deemed most appropriate by the fellow and program director. The goal will be to have completed an abstract and/or manuscript by the end of the fellowship.
MD Anderson Cancer Center is committed to encouraging good health and staying true to our mission to end cancer. If you are applying for a GME fellowship or residency program starting on or after July 1, 2016, please be advised that MD Anderson will have instituted a tobacco-free hiring process as part of its efforts to achieve these goals. If you are offered an appointment, you will be subject to a Pre-Employment Drug Screen for tobacco compounds in compliance with applicable state laws. If you do not pass the urine drug screening which includes testing for tobacco compounds, you CANNOT be appointed at MD Anderson. Should you fail to meet this contingency, MD Anderson will withdraw your offer of appointment for the academic year. You may reapply for the following academic year, but there are no guarantees that you will be offered a position as many of our programs are already filled for several years out.